Creative Medical Technolo...

NASDAQ: CELZ · Real-Time Price · USD
3.05
-0.02 (-0.65%)
At close: Aug 15, 2025, 3:59 PM
3.12
2.30%
After-hours: Aug 15, 2025, 06:53 PM EDT

Creative Medical Technology Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-1.23M -1.64M -1.85M -1.04M -1.56M -1.04M -1.68M -1.45M -1.1M -1.05M -6.22M -982.34K -1.79M -1.15M -3.88M -1.84M -2.91M 27.84M
Depreciation & Amortization
30.74K 30.58K 22.64K 29.27K 29.27K 29.27K 25.52K 23.02K 23.02K 23.02K 23.02K 23.02K 23.02K 23.02K 23.02K 23.02K 23.02K 23.02K
Stock-Based Compensation
n/a 3.48K 9.16K 9.16K 9.16K 9.16K 9.16K 9.16K 9.16K 9.16K 9.16K 9.16K 9.06K 41.36K 211.77K 383.61K n/a n/a
Other Working Capital
n/a 12.64K -128.1K 64.48K 61.48K 86.68K -168.44K 92.21K 92.21K 2.91M -350.63K 54.96K 35K -59.42K -5.62K -51.69K 63.83K -154.67K
Other Non-Cash Items
43.81K n/a n/a 172.35K n/a n/a 74.68K 30.17K 64.21K 2.97M -2.89M 17.16K 12.59K 514.38K 2.4M 1.3M 2.59M -28.15M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -108.77K -30.17K -64.21K -2.97M 2.89M n/a -12.59K n/a -211.77K -295.11K n/a n/a
Change in Working Capital
n/a 12.5K -127.26K -156.24K 49.99K 106.25K -217K 117.25K 83.2K -2.82M 2.59M 76.85K 3.52K -486.4K 288.37K 37.8K 72.87K -149.57K
Operating Cash Flow
-1.16M -1.59M -1.95M -985.59K -1.47M -896.86K -1.89M -1.3M -986.74K -3.84M -3.59M -873.3K -1.76M -1.58M -1.16M -390.79K -222.14K -441.52K
Capital Expenditures
n/a n/a n/a -4 4.00 4.00 -100K 3.00 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a -22.85M -2.08M n/a n/a -5.06M -5.02M n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a -6.52M n/a 6.52M 26.4M 4M 11.13K 5.04M n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a 6.32M -4 n/a -2.32M -100K -4.55M 5.04M -5.06M -5.02M n/a n/a 200K -200K n/a n/a
Investing Cash Flow
n/a n/a n/a -200K n/a 6.52M 1.13M 1.82M -4.54M 5.04M -5.06M -5.02M n/a n/a 200K -200K n/a n/a
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 3.48M n/a 134.64K
Common Stock Repurchased
n/a -10K 174.96K -25.45K -66.72K -82.8K -270.95K -191.78K n/a n/a n/a n/a n/a n/a -169.03K n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -27.73K n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a n/a 100.00 n/a n/a n/a n/a n/a n/a 12.00 15.47M n/a 9.34M -666.52K 105.59K 22K
Financial Cash Flow
n/a 3.35M 1.63M -25.45K -66.62K -82.8K -270.95K -191.78K n/a n/a -15.47M 12.00 15.47M n/a 9.31M 2.81M 105.59K 618.64K
Net Cash Flow
-1.16M 1.76M -320.04K -1.21M -1.54M 5.54M -1.04M 517.56K -5.53M 1.2M -8.65M -5.89M 13.72M -1.58M 8.35M 2.22M -116.55K 177.12K
Free Cash Flow
-1.16M -1.59M -1.95M -985.59K -1.47M -896.86K -1.99M -1.3M -986.74K -3.84M -3.59M -873.3K -1.76M -1.58M -1.16M -390.79K -222.14K -441.52K